Business
CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st
REHOVOT, Israel, Oct. 14, 2021 /PRNewswire/ - CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative
About this update from Collplant Biotechnologies Ltd.
[{"type":"text","content":"REHOVOT, Israel, Oct. 14, 2021 /PRNewswire/ - CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that the Company's Deputy CEO & Chief Financial Officer Eran Rotem, will present a company overview at the Dawson James 6th Annual Small Cap Growth Conference at the Wyndham Grand Hotel in Jupiter, Florida.\n\n \n \n \n \n \n \n\n \nMr. Rotem's presentation will take place on Thursday, October 21 at 12:15-12:35 PM ET. \nInvestors attending the event may request a one-on-one meeting through the conference coordinators.\nAbout CollPlant\nCollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its recombinant human collagen produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine. \nAt the beginning of 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. Later in 2021, CollPlant entered into a strategic co-development agreement with 3D Systems for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant.\nFor more information, visit http://www.collplant.com.\nSafe Harbor Statements\nThis press release may include forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to CollPlant's objectives plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that CollPlant intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as \"believes,\" \"hopes,\" \"may,\" \"anticipates,\" \"should,\" \"intends,\" \"plans,\" \"will,\" \"expects,\" \"estimates,\" \"projects,\" \"positioned,\" \"strategy\" and similar expressions and are based on assumptions and assessments made in...